Navigation Links
Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C
Date:3/9/2009

erence call will be available within a few hours after the call ends. Investors may listen to the replay by dialing (888) 203-1112 or (719) 457-0820 confirmation code 4076361. Today's conference call also will be webcast and can be accessed at www.hgsi.com. Investors interested in listening to the live webcast should log on before the conference call begins to download any software required. Both the audio replay and the archive of the conference call webcast will remain available for several days.

About Human Genome Sciences

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax and cancer.

The Company's primary focus is rapid progress toward the commercialization of its two lead drugs, Albuferon(R) (albinterferon alfa-2b) for hepatitis C and LymphoStat-B(R) (belimumab) for lupus. Albuferon has now completed Phase 3 development, and the filing of global marketing applications is expected in fall 2009. Two Phase 3 clinical trials of LymphoStat-B are ongoing, with results expected in July and November 2009.

In January 2009, HGS began delivery of 20,000 doses of ABthrax(TM) (raxibacumab) to the U.S. Strategic National Stockpile for use in the event of an emergency for the treatment of inhalation anthrax. The Company also has several drugs in earlier stages of clinical development for the treatment of cancer, led by the TRAIL receptor antibody HGS-ETR1 and a small-molecule antagonist of IAP (inhibitor of apoptosis) proteins. In addition, HGS has substantial financial rights to certain products in the GSK clinical pipeline including darapladib, currently in Phase 3 development as a potential treatment for coronary heart disease, and Syncria(R) (albiglutide), curren
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Drug Development Program Started Based on CAP(R) Human Cell Line
2. Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
3. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
4. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
5. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
6. Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs
7. Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
8. Mardil Inc. Advances Its Novel Cardiac Device to First-In-Human Trials for Mitral Valve Regurgitation
9. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
10. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
11. Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 Sono-Tek Corporation (OTC BB: SOTK) today announced ... 2013, compared to sales of $2,202,000 for the prior year ... quarter has also shown growth over the preceding quarter,s sales, ... this fiscal year. Markets that experienced sales increases over the ...
(Date:1/15/2014)... RAPIDS, Mich. , Jan. 15, 2014 As health ... the flu virus, select Meijer pharmacies in Michigan ... strep throat to eligible patients, enabling Meijer pharmacists to administer ... strict protocol set by a physician participating in the study. ...
(Date:1/15/2014)... THOUSAND OAKS, Calif. , Jan. 15, 2014 ... and Amgen (NASDAQ: AMGN ) announced ... to jointly discover and validate new therapeutic targets ... (IBD), a chronic disorder that affects millions worldwide. ...
Breaking Medicine Technology:Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4
... legislators seek ways to reduce Medicaid spending, they should start ... fee-for-service model to the more efficient model used in some ... study finds that the program could save $473 million ... benefits more like those in Medicare and commercial plans. Governors ...
... Remedi SeniorCare®, which is among the nation,s ... care (LTC) pharmacy industry with the Paxit™ med-pass ... enabled by fully automated centralized proprietary dispensing technology. ... in Maryland and the Washington, D.C. area, where ...
Cached Medicine Technology:Budget Solution? Modernizing Medicaid Pharmacy Could Save Florida $473 Million 2Remedi SeniorCare Expands Distribution of the Paxit™ Med-Pass Solution, the New Standard in Medication Administration 2Remedi SeniorCare Expands Distribution of the Paxit™ Med-Pass Solution, the New Standard in Medication Administration 3Remedi SeniorCare Expands Distribution of the Paxit™ Med-Pass Solution, the New Standard in Medication Administration 4
(Date:7/11/2014)... UT (PRWEB) July 11, 2014 WWTrek ... at the Kilimanjaro Kids Community in Tanzania. Opened in 2012, ... 150 chickens, and two cows. HOP Founder, Dean Cardinale, started ... for some of the orphaned children he encountered while running ... Team visited the children, who have all made astounding progress ...
(Date:7/11/2014)... as medicine, according to a QUT study that ... to reducing the risk of death in older ... of Health and Biomedical Innovation, said that in ... health, health professionals should be prescribing tailored exercise ... QUT,s Dr Charlotte Seib co-authored a paper published ...
(Date:7/11/2014)... Johnson, owner of the Portland Fit Body Boot Camp, has already ... held two charity workout events and is about to hold its ... 8:30 at Col Summers City Park, SE 20th and Belmont, Portland, ... for Medical Teams International. Their second workout event resulted in a ... 26th, Johnson and Portland Fit Body Boot Camp hope ...
(Date:7/11/2014)... 11, 2014 H.E.A.R Me Out Listens ... launches this week to provide comprehensive information and services ... half a million Coloradoans with hearing loss, this organization ... encompassing information of the local and state resources that ... hearing impaired. , H.E.A.R. Me Out and its website ...
(Date:7/11/2014)... Leeds, England (PRWEB) July 11, 2014 Having ... later as a member of mental hospital staff, Roger Grainger ... among medical professionals in his new book, “You Never Get ... 4 people in the United Kingdom will experience some kind ... , “Society still needs to take a look at ...
Breaking Medicine News(10 mins):Health News:Human Outreach Project Sees Incredible Progress in the Kilimanjaro Kids Community 2Health News:Exercise is the best medicine: QUT study 2Health News:Portland Fit Body Boot Camp Invites Public to Fitness Boot Camp Session Benefiting Children’s Cancer Association 2Health News:Portland Fit Body Boot Camp Invites Public to Fitness Boot Camp Session Benefiting Children’s Cancer Association 3Health News:H.E.A.R Me Out Listens to Needs of Hearing Impaired 2Health News:H.E.A.R Me Out Listens to Needs of Hearing Impaired 3Health News:Psychiatric Hospital Patient and Registered Psychologist Explores Mental Health and Therapy in New Book "You Never Get Out" 2
... is good for the heart. A recent study undertaken by Robert// ... School has found that by eating fish regularly, the risk ... a lower risk of cardiovascular problems. , ,The substance ... lean varieties such as salmon. The study used more than 3,000 ...
... A large new study reports that Vitamin E is unlikely ... the risk of heart attacks and stroke in older women. ... Pauling Institute at Oregon State University and an expert on ... to reduce the risk of heart and other serious degenerative ...
... age of 60 and above can have less back pain ... back supporting device and doing some special exercises. ,In ... said that the new specially weighed back support device can ... extensive improvements in strength for the women who had suffered ...
... Prayers can help heart patients in the recovery process ... // University Medical Centre. Researchers said cardiac patients using ... heart failure, post-procedural ischemia or heart attack,than those without ... to April 1998 with symptoms of acute coronary ischemia. ...
... and colleagues compared their Cell culture small pox vaccine// ... vaccine. Small pox vaccine currently used is a live, ... produces adverse effects in vaccinated, 15-42 develop serious or ... 2 people every million die because of this vaccine. ...
... of osteoporosis is useful, but changes in bone// mineral ... are anti-resorptive agents that prevent bone breakdown. ,For ... that enhances bone formation is preferable, and this is ... (PTH). However, the use of PTH is limited by ...
Cached Medicine News:Health News:The Benefits of Strontium in the treatment for Osteoporosis Questioned 2
Adson bipolar forceps, 12 cm, straight....
Straight, blunt and pointed tips....
Angulated, blunt and pointed tips....
Blunt, 20 cm long....
Medicine Products: